INDOLYLMALEIMIDE DERIVATIVES, METHOD OF THEIR OBTAINING, THEIR APPLICATION AND PHARMACEUICAL COMPOSITION FOR TREATMENT OR PREVENTION OF T-LYMPHOCYTE AND/OR "ПКС"- MEDIATED DISORDERS OR DISEASES Russian patent published in 2008 - IPC C07D403/04 C07D403/14 C07D401/14 A61K31/404 A61K31/4709 A61K31/4725 A61P29/00 A61P7/00 

Abstract RU 2340610 C2

FIELD: chemistry.

SUBSTANCE: invention relates to compounds of formula (I) , in which Ra is H, CH3 or isopropyl, Rb is H, halogen, C1-6alkoxygroup or C1-6alkyl, and or I. R is radical of formula (b) , R4 is 1-pyperasinyl, substituted with CH3 in positions 3 and/or 4, Ra is not H or CH3, when R4 is 4-methyl-1-pyperazinyl; or III. R is remaining part of formula (c) , in which R14 is 1-pyperazinyl, optionally substituted with CH3 in position 3; or 4,7-diase-spiro[2,5]oct-7-yl, R15 is halogen, CF3 or CH3, R15 is not CH3, when R16 stands for CH3, Ra is H or CH3, Rb is H, and R14 is 4-methyl-1-pyperazinyl, and R16 is H, CH3 or CF3, R16 is not H, when R15 is Cl, Ra is H or CH3, Rb is H, and R14 is 4-methyl-1-pyperazinyl, or IV. R is radical of formula (d) , in which R8 is 1-pyperazinyl, 3- methyl-1-pyperazin-l-yl or 4-benzyl-pyperazin-1-yl, or V. R is radical of formula (e) , in which R9 is 4,7-diase-spiro[2,5]oct-7-yl or pyperazin-1-yl, substituted in position 3 with ethyl, or its salt, method of their production, based on them pharmaceutical composition and application for obtaining medication for treatment or prevention of T-lymphocyte and-or "ПКС"-mediated diseases or disorders.

EFFECT: increase of composition and treatment method efficiency.

12 cl, 5 tbl, 32 ex

Similar patents RU2340610C2

Title Year Author Number
SUBSTITUTED N2-(4-AMINO-2-METHOXYPHENYL)-N4-[2-(DIMETHYLPHOSPHORYL)-PHENYL]-5-CHLORO-PYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, APPLICABLE FOR TREATING CANCER 2015
  • Ivashchenko Aleksandr Vasilevich
  • Ignatev Vasilij Gennadevich
  • Repik Aleksej Evgenevich
  • Shafeev Mikhail Ajratovich
RU2607371C1
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY 2016
  • Kessari Dzhanni
  • Govard Stiven
  • Bak Ildiko Mariya
  • Kons Bendzhamin Devid
  • Dzhonson Kristofer Norbert
  • Kholvi Rian Sara
  • Ris Devid Charlz
  • St. Denis Dzheffri Devid
  • Tamanini Emiliano
  • Golding Bernard Tomas
  • Khardkasl Ian Robert
  • Kano Selin Florens
  • Miller Dunkan Charlz
  • Kalli Sara
  • Noubl Martin Edvard Myantyulya
  • Griffin Rodzher Dzhon
  • Osborn Dzhejms Deniel
  • Pich Dzhoan
  • Lyuis Aruel
  • Kherst Kim Luiza
  • Uittaker Bendzhamin Pol
  • Uotson Devid Uin
  • Mitchell Dejl Robert
RU2794333C1
QUINOLINE DERIVATIVES AS SMO INHIBITORS 2015
  • Wu Hao
  • Long Chaofeng
  • Lin Jun
  • Chen Xiaoxin
  • Li Yunhui
  • Liu Zhuowei
  • Wei Changqing
  • Chen Lijuan
  • Chen Shuhui
RU2695815C2
NEW COMPOUNDS - NEUROKININ 1 RECEPTOR ANTAGONIZER 2013
  • Serensen Morten Dal
  • Di Fabio Romano
  • Potstsan Alfonso
  • Katalani Mariya Piya
  • Bladkh Khokon
  • Felding Yakob
RU2631319C2
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE 2010
  • Blaker Nikol
  • Do Stiven
  • Dadli Danette
  • Folks Adrian Dzh.
  • Khild Robert
  • Kheffron Timoti
  • Dzhons Mark
  • Kolesnikov Aleksandr
  • Ndubaku Chudi
  • Olivero Alan G.
  • Prajs Stiven
  • Stejben Stiven
  • Van Lan
RU2654068C1
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE 2010
  • Nikol Blaker
  • Stiven Do
  • Danette Dadli
  • Adrian Dzh. Folks
  • Robert Khild
  • Timoti Kheffron
  • Mark Dzhons
  • Aleksandr Kolesnikov
  • Chudi Ndubaku
  • Alan G. Olivero
  • Stiven Prajs
  • Stiven Stejben
  • Lan Van
RU2600927C2
ANALOGUES OF 4H-PYRAZOLO[1,5-A]BENZIMIDAZOLE COMPOUNDS AS PARP INHIBITORS 2015
  • Van Syuekhaj
  • Din Chzhaochzhun
  • Syuj Yun
  • Chen Shukhuej
  • Li Le
  • Li Gan
  • Tu Zhunkhua
  • Van Tsajlin
  • Yue Yan
  • Chzhan Chzhibo
  • Chen Khajlyan
  • Sun Ventsze
  • Khuan Lu
RU2672722C2
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS 2011
  • Borr'Ello Manuehla
  • Puchchi Sabrina
  • Stazi Luidzhi P'Ero
  • Rovati Luchio
RU2565596C2
DIARYL HYDANTOINS 2011
  • Sojers Charlz L.
  • Yung Majkl E.
  • Chen Charli D.
  • Ouk Samedi
  • Uelsbi Derek
  • Tran Kris
  • Vongvajpat Dzhon
  • Uo Dongvon
RU2638833C2
VASOPRESSIN V RECEPTOR ANTAGONISTS 2005
  • Andzhej Roman Batt
  • Bakster Ehndrju Dzhon
  • Khini Selin
  • Stokli Martin Li
  • Brajan Ro Majkl
  • Khadson Piter
  • Khehndi Rejchel
RU2370497C2

RU 2 340 610 C2

Authors

Ehvenu Zhan-P'Er

Fon-Matt Peter

Vagner Jurgen

Tsenke Gerkhard

Dates

2008-12-10Published

2003-04-02Filed